Tag | Content |
---|
EnhancerAtlas ID | HS092-08507 |
Organism | Homo sapiens |
Tissue/cell | HFF |
Coordinate | chr11:10571750-10573770 |
TF binding sites/motifs | TF | JASPAR ID | Coordinate | Motif Sequence | Strand | -Log10(p-value) |
ESRRB | MA0141.3 | chr11:10573388-10573399 | TCAAGGTCAAA | + | 6.14 | Esrra | MA0592.2 | chr11:10573387-10573398 | TTCAAGGTCAA | + | 6.14 | MNX1 | MA0707.1 | chr11:10572176-10572186 | TTTAATTACC | - | 6.02 |
|
| Number of super-enhancer constituents: 2 | ID | Coordinate | Tissue/cell |
SE_68259 | chr11:10558710-10584567 | TC32 | SE_68548 | chr11:10556981-10581695 | TC71 |
|
| Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder | Number of disease enhancers: 2 | Chromosome | Start | End |
chr11 | 10572194 | 10572333 | chr11 | 10572120 | 10572478 |
|
| Number: 1 | ID | Chromosome | Start | End |
GH11I010550 | chr11 | 10572181 | 10572370 |
|
Enhancer Sequence | GGCTAATTTT TTGTATTTTT AGTAGAGACG GGGTTTCACC GTGTTAGCCA GGATGATCTT 60 GATCTCCCGA CCTCATGATC CGCCTGCCTT GGCTTCCCAA AGTGCTGGGA TTACAGGTGT 120 GAGCCAGCGT GCCTGGCCAG TCTTTTGGTA TTCTTAATTG ATTTTGTCTT TTTTTCTATC 180 ACAAAAATAT TTTCAACTTC ACTGAAGGCA AAATTCAAAC AAAATAACAG TGGAGTGGTA 240 AAATGAGTCT GGAAGTTATC AAAAAGGATT CTAATTTTCA GAAAATGATG GCAATCTAAA 300 ATTCTGCACT AAATGCTAAG AAAGCGTCCT AGGCTTCAAA GACTAAAATA GAAATATAGA 360 GACCAAGGAA TCAAATTTTT GCCAATACTT ATTAGCTTTG TTGTTACTGA GGGAACTCAA 420 TTTGTTTTTA ATTACCCACA GTCCAAAACA CACTGCAGTT TAGTTTCTCT ATTAAGATAA 480 ATATCAGTTT GACTTACAGA AGTGAGTCAA TGGCCAACTC AGAGAGTAAA GTTCAAGTAT 540 AGTAGCCTTT ATGCATTCTT CTGGCTTGTT CATAGTTGCA TTCTACACCA AAATAAAGTA 600 TTCAAGAAGA ACAAAATTTA AGTGGACAGA AACAGTTAGC CCTGTACTGA GTGACCTTAG 660 CACTTAATGC AGATAACTGG ATAAAGGTAT AACTTGCAGC TCATGAAATC TCAGTGAATA 720 AATGTATACA TGATGAATGT ATATACATGT ATTCATTCAA CATTTACTCA CAGCCTACTC 780 AGTAAATGTG CTAGATTTAC ATATACTACC CAAGTGCTAA GAATGCAAGG AAAAATAAAA 840 TATGTACACA ATTAACATAA TACAATGTGG CATATAACAC AGATGTGTAA ACAAATTTTA 900 AAAAGAAAGA ATGAGAAAAA TTCATTAATG TGATAGGAGG CAGCCTTCTA AAATGGCTCC 960 CAATGATCTC CTCATCTTGG TATTCATGCC CTTGTATAAT CCCTTCCACT TAAGCATGGG 1020 CTGGACATAG TGACTTGCTT CCAATGAATA AAATATGGCA AAAATAATCG GATGTCACTT 1080 CGAAGATTAG ATCTAAAAGA TTATAACTTT CATCTTGCCA GCACGCTTCC TCTCTGGCTC 1140 TTCTTGCTTA TTGCTCTGAT GAAGCAAACC GCTATTTTGT GAGCTGTCCC AAAGGGGAGG 1200 TTTGCTAGGA AAGAACTGAG GGTAGCCTTT GGCCAACTGC AAACAAGGAA TTAATCCTGT 1260 CAACAACCAT GCGAGTGAGC TTGAAAGTTA ATTCTATTCC AGTCAAATCC TGAGATGACT 1320 AAGCCCTGGA AGACAGTTGA ATTGCAGCTT TGTGAGAGAC CCCGAAGCAG GGGACCCAGT 1380 TACCCATGCC TGGTTTCCTG ATCCACAACA ATGTTAGATA ATAAATGCTG TAAAAGTCAT 1440 GAAGTTTTTA GATAATTTGC TTTTCAACAA TTGATAACTC ATACAATTAG GAAGAAAAGG 1500 AAGGTGATTA AAATAGAAGG AATGGCAGTT GCAAAATGAG AGGGCATCGT ACAGATTAAA 1560 TTCTAGAATG GTAAATGAAT TTGTGTAGCC ATAGCATGAA GTATCCTTGC AGGAATGAAT 1620 AAGATTTGAG AAGAGGATTC AAGGTCAAAT TGTAAAATGC ACTCAGTGTC ATTTATTTCA 1680 CTGTTCCCTT ACAGAAAACT TGCCAACTAT TTTAAACAAC AAAAAAAAGT TTAAGACAGG 1740 AAATTAGGTA CTTATAAAAT TATTGGAAGG GCTGGAGAAA TAATTTCTGG TCTCAGCCCC 1800 AGGAATGCCT CCCAGAGCAA TTATCTCTGA ATGGGTCCAC TAGGGAAGCT TCCGTCTCCT 1860 CTATAATAAG AAAAGTGGGG AAGCAGGAGA TGCAACTGTA ATAGGTCTGT TGCTCAATGT 1920 GCATGGGAAG TCAATATGCC AAGACGCAGG GGTTGCAGCA GAGAAAGAGG TTTAATCATA 1980 GATAGGGCTG CTGAACAAGG AGACAGAAGG AAACTTCAAA 2020
|